Molecular assay may help identify NSCLC patients who could benefit from adjuvant chemotherapy
Dr Henschke, Prof Field, Dr Pastorino, Dr Di Meco debate and answer questions arising from the 'Screening, surgical cure and new developments' session at the Future Horizons in Lung Cancer meeting.
Molecular assay may help identify NSCLC patients who could benefit from adjuvant chemotherapy
ESMO 2024: Optimising the personalisation of prostate cancer treatment
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
SABCS 2023: Latest breast cancer diagnostics guidelines
Genomic testing: Awareness and effective communication between healthcare professionals and patients
A reproducibility study in pulmonary adenocarcinomas supports a revised classification
War in Ukraine: The Global Medical Knowledge Alliance's response to improving cancer care
Choosing Wisely in radiology Tanzania
Lung cancer screening and treatment in the Philippines